Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Current Assets (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Current Assets for 4 consecutive years, with $107.9 million as the latest value for Q4 2025.

  • Quarterly Current Assets rose 56.01% to $107.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $107.9 million through Dec 2025, up 56.01% year-over-year, with the annual reading at $107.9 million for FY2025, 56.01% up from the prior year.
  • Current Assets for Q4 2025 was $107.9 million at Orchestra BioMed Holdings, up from $97.8 million in the prior quarter.
  • The five-year high for Current Assets was $129.9 million in Q1 2023, with the low at $872555.0 in Q3 2022.
  • Average Current Assets over 4 years is $69.5 million, with a median of $72.8 million recorded in 2024.
  • The sharpest move saw Current Assets surged 12528.32% in 2023, then tumbled 46.03% in 2025.
  • Over 4 years, Current Assets stood at $84.7 million in 2022, then grew by 5.22% to $89.1 million in 2023, then decreased by 22.38% to $69.2 million in 2024, then surged by 56.01% to $107.9 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $107.9 million, $97.8 million, and $35.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.